Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Fuji
Teva
US Army
UBS

Generated: May 24, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019445

« Back to Dashboard

NDA 019445 describes DEXTROSE 50% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare, Hospira, and Icu Medical Inc, and is included in five NDAs. It is available from eight suppliers. Additional details are available on the DEXTROSE 50% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 50% IN PLASTIC CONTAINER is dextrose. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for 019445
Tradename:DEXTROSE 50% IN PLASTIC CONTAINER
Applicant:Hospira
Ingredient:dextrose
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019445
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 25% dextrose INJECTABLE;INJECTION 019445 NDA Hospira, Inc. 0409-1775 0409-1775-10 10 CARTON in 1 PACKAGE (0409-1775-10) > 1 SYRINGE, PLASTIC in 1 CARTON > 10 mL in 1 SYRINGE, PLASTIC
DEXTROSE 25% dextrose INJECTABLE;INJECTION 019445 NDA Hospira, Inc. 0409-6648 0409-6648-02 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-6648-02) > 50 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/ML
Approval Date:Jun 3, 1986TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength250MG/ML
Approval Date:Nov 23, 1998TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/ML
Approval Date:Sep 3, 2014TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fuji
Fish and Richardson
Chubb
Cipla
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.